Magic mushroom compound could help veterans heal from PTSD

NCT ID NCT07332143

Not yet recruiting Symptom relief Sponsor: Emory University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether the psychedelic drug psilocybin, combined with talk therapy, can safely reduce PTSD symptoms in Georgia military veterans. 150 veterans will be randomly assigned to different therapy approaches to compare results. The goal is to see if this combination is safe, tolerable, and effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: psilocybin
What this could lead to: If it works, this could point toward a new treatment option for PTSD that combines a psychedelic drug with talk therapy.
What could go wrong: This is an early Phase 2 pilot study with only 150 participants, so results may not apply to all veterans. Psilocybin can cause intense psychological effects and is not yet approved for PTSD.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PTSD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

post-traumatic stress disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PTSD

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Emory University Hospital

Atlanta, Georgia, 30322, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.